Mariner’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20M | Sell |
68,255
-11,502
| -14% | -$3.78M | 0.02% | 471 |
|
|
2025
Q4 | $28M | Buy |
79,757
+466
| +0.6% | +$157K | 0.03% | 360 |
|
|
2025
Q3 | $25.6M | Buy |
79,291
+574
| +0.7% | +$179K | 0.03% | 366 |
|
|
2025
Q2 | $30.6M | Sell |
78,717
-556
| -0.7% | -$224K | 0.04% | 321 |
|
|
2025
Q1 | $34.5M | Buy |
79,273
+5,567
| +8% | +$2.23M | 0.06% | 272 |
|
|
2024
Q4 | $27.2M | Sell |
73,706
-11,891
| -14% | -$4.98M | 0.05% | 304 |
|
|
2024
Q3 | $44.5M | Buy |
85,597
+1,053
| +1% | +$563K | 0.08% | 223 |
|
|
2024
Q2 | $45.8M | Buy |
84,544
+3,012
| +4% | +$1.59M | 0.09% | 207 |
|
|
2024
Q1 | $42.3M | Sell |
81,532
-595
| -0.7% | -$296K | 0.09% | 212 |
|
|
2023
Q4 | $38.7M | Sell |
82,127
-2,482
| -3% | -$1.15M | 0.09% | 203 |
|
|
2023
Q3 | $36.8M | Sell |
84,609
-30,538
| -27% | -$13.9M | 0.1% | 192 |
|
|
2023
Q2 | $51.2M | Sell |
115,147
-1,446
| -1% | -$667K | 0.14% | 146 |
|
|
2023
Q1 | $53.6M | Buy |
116,593
+1,233
| +1% | +$587K | 0.16% | 133 |
|
|
2022
Q4 | $59.2M | Sell |
115,360
-346
| -0.3% | -$176K | 0.19% | 116 |
|
|
2022
Q3 | $52.6M | Buy |
115,706
+54,292
| +88% | +$26M | 0.21% | 114 |
|
|
2022
Q2 | $29.6M | Sell |
61,414
-4,116
| -6% | -$2.04M | 0.12% | 182 |
|
|
2022
Q1 | $32.2M | Buy |
65,530
+23,121
| +55% | +$10.6M | 0.12% | 183 |
|
|
2021
Q4 | $19.7M | Buy |
42,409
+1,750
| +4% | +$736K | 0.08% | 219 |
|
|
2021
Q3 | $15.2M | Sell |
40,659
-1,281
| -3% | -$487K | 0.08% | 226 |
|
|
2021
Q2 | $16M | Buy |
41,940
+1,028
| +3% | +$393K | 0.1% | 193 |
|
|
2021
Q1 | $14.7M | Sell |
40,912
-2,534
| -6% | -$815K | 0.1% | 185 |
|
|
2020
Q4 | $13.9M | Buy |
43,446
+1,000
| +2% | +$307K | 0.11% | 187 |
|
|
2020
Q3 | $11.4M | Buy |
+42,446
| New | +$11.4M | 0.11% | 184 |
|
|
2019
Q3 | – | Sell |
-5,511
| Closed | -$1.55M | – | 781 |
|
|
2019
Q2 | $1.55M | Buy |
5,511
+1,248
| +29% | +$341K | 0.02% | 436 |
|
|
2019
Q1 | $1.22M | Buy |
4,263
+666
| +19% | +$193K | 0.02% | 455 |
|
|
2018
Q4 | $945K | Buy |
3,597
+432
| +14% | +$119K | 0.02% | 446 |
|
|
2018
Q3 | $867K | Buy |
3,165
+552
| +21% | +$143K | 0.02% | 443 |
|
|
2018
Q2 | $622K | Buy |
2,613
+702
| +37% | +$163K | 0.02% | 494 |
|
|
2018
Q1 | $420K | Buy |
1,911
+639
| +50% | +$150K | 0.02% | 466 |
|
|
2017
Q4 | $286K | Buy |
+1,272
| New | +$271K | 0.01% | 470 |
|
Other funds holding ELV
VCM
VPM
Mariner's ELV Position: Q1 2026 in Review
Mariner reduced its Elevance Health (ELV) stake by 14% in Q1 2026, selling an estimated $3.78M and leaving 68,255 shares worth $20M. The position accounts for 0.02% of the portfolio, ranked #471.
Mariner first reported a position in ELV in Q4 2017 and has held it in 30 quarters since. The position peaked at $59.2M in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Mariner held 68,255 shares of Elevance Health worth $20M as of Q1 2026.
- Mariner sold 11,502 Elevance Health shares in Q1 2026, an estimated $3.78M.
- Elevance Health made up 0.02% of Mariner's portfolio in Q1 2026, its #471 holding.
- Mariner first reported a position in Elevance Health in Q4 2017 and has held it in 30 quarters since.
- Mariner's Elevance Health position peaked at $59.2M in Q4 2022.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.